HIV News and Research

RSS

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

Newly discovered immune pathway prevents fatal fungal infections in mice

An immune pathway has been discovered which prevents a normally harmless fungus developing into a fatal infection.

5 Aug 2026

Newly-discovered protein acts as off switch for human immune cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.

3 Aug 2026

Children remain more vulnerable to influenza despite protective antibody levels

Researchers analyzing 1,518 South African household participants found that higher pre-season antibody titers were associated with lower infection risk for three of four influenza viruses studied. Children remained more susceptible after accounting for measured exposure and antibody titers, while younger children shed viral RNA longer than older adults.

3 Aug 2026

Biotherapeutic metabolite repairs gut damage caused by HIV infection

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.

30 Jul 2026

Texas A&M researchers build AI tools for tuberculosis drug discovery

When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later prove to be costly dead ends.

30 Jul 2026

Once-weekly oral tablet proves highly effective for HIV care

An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as one of today's leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.

29 Jul 2026

Scientists discover why mouse liver cells resist hepatitis E virus

Mouse liver cells are not a suitable host for hepatitis E viruses. The Virology department in Bochum has discovered why.

29 Jul 2026

Integration is key to fighting global epidemics, WHO reports

The World Health Organization (WHO) today launched a new report assessing progress in implementing the Global Health Sector Strategies (GHSS) on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022–2030.

28 Jul 2026

Landmark study identifies new genetic risk factors linked to fibromyalgia syndrome

In a landmark study published in Nature Medicine, an international team of researchers has identified new genetic risk factors associated with fibromyalgia syndrome.

28 Jul 2026

AI-powered analytics and experimental validation: Transforming target identification in drug discovery

Discover how AI-powered analytics and experimental validation combine to improve target identification and accelerate drug discovery success.

From Axxam S.p.A 23 Jul 2026

Racial and geographic disparities continue affecting stroke treatment outcomes

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting found that racial, geographic and socioeconomic disparities continue to influence stroke treatment and outcomes across the United States.

22 Jul 2026

Infectious disease expert explains who faces the highest risk from cyclosporiasis

People across the United States are taking a closer look at their lettuce and leafy greens this summer thanks to an outbreak of cyclosporiasis, a gastrointestinal illness that causes several symptoms, the most notable being severe, watery diarrhea.

19 Jul 2026

Evidence does not support universal vitamin D supplementation to prevent preterm birth

Announcing a new article publication in BIO Integration. Preterm birth complications are among leading causes of mortality in neonates and children under 5 years of age worldwide.

15 Jul 2026

Tracking Lassa fever survivors provides crucial clues for future vaccines

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the launch of a research study to understand how Lassa fever survivors fight and overcome Lassa virus infection.

14 Jul 2026

Sexual and gender minority populations are less likely to receive cancer screening

A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need for equitable healthcare access.

8 Jul 2026

New viral insights lay foundation for treating infection with JC polyomaviruses

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.

6 Jul 2026

New HIV vaccine successfully generates broadly neutralizing antibodies in primates

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS.

6 Jul 2026

Overlooked parasitic disease linked to HIV and cervical cancer risk

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

3 Jul 2026